| Authors: |
Muir A; Immunology Programme, The Babraham Institute, Cambridge, United Kingdom., Paudyal B; The Pirbright Institute, Pirbright, United Kingdom., Schmidt S; The Pirbright Institute, Pirbright, United Kingdom., Sedaghat-Rostami E; The Pirbright Institute, Pirbright, United Kingdom., Chakravarti S; The Pirbright Institute, Pirbright, United Kingdom., Villanueva-Hernández S; The Pirbright Institute, Pirbright, United Kingdom., Moffat K; The Pirbright Institute, Pirbright, United Kingdom., Polo N; The Pirbright Institute, Pirbright, United Kingdom., Angelopoulos N; The Pirbright Institute, Pirbright, United Kingdom., Schmidt A; Virologisches Institut-Klinische und Molekulare Virologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.; FAU Profilzentrum Immunmedizin (FAU I-MED), Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany., Tenbusch M; Virologisches Institut-Klinische und Molekulare Virologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.; FAU Profilzentrum Immunmedizin (FAU I-MED), Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany., Freimanis G; The Pirbright Institute, Pirbright, United Kingdom., Gerner W; The Pirbright Institute, Pirbright, United Kingdom., Richard AC; Immunology Programme, The Babraham Institute, Cambridge, United Kingdom., Tchilian E; The Pirbright Institute, Pirbright, United Kingdom. |